Therapeutic antibodies are increasingly being used in the clinic for the treatment of various diseases. Yet, oral to gut targeting of antibodies remains a challenge due to their incapability to survive digestion and reach gastrointestinal tissues. Now, scientists have developed a new antibody technology that combines the advantages of antibody-based therapies with the convenience of oral drug administration.
from Latest Science News -- ScienceDaily https://ift.tt/2FP5LwM
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment